Eudocia Q Lee
National Cancer Institute (NCI) · NRG Oncology
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Eudocia Q Lee as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:40 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT02133183 · Sapanisertib Before and After Surgery in Treating Patients With Recurrent GlioblastomaNational Cancer Institute (NCI) · terminated · Glioblastoma, Gliosarcoma · principal investigator
- Ph1NCT01849146 · Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent GlioblastomaNational Cancer Institute (NCI) · completed · Glioblastoma, Recurrent Glioblastoma · principal investigator
- Ph2NCT01609790 · Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain TumorsNational Cancer Institute (NCI) · completed · Giant Cell Glioblastoma, Glioblastoma, Gliosarcoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:40 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Adult Brain Tumor Consortium (ABTC)U01CA137443 · NCI · JOHNS HOPKINS UNIVERSITY · PI STUART A GROSSMAN, MICHAEL D PRADOS · fiscal years 2009 to 2013Named on NCT02133183
- Adult Brain Tumor Consortium (ABTC)UM1CA137443 · NCI · JOHNS HOPKINS UNIVERSITY · PI STUART A GROSSMAN · fiscal years 2014 to 2020Named on NCT02133183, NCT01849146
- NRG Oncology Network Group Operations CenterU10CA180868 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI Quynh-Thu Xuan Le, ROBERT S. MANNEL, NORMAN WOLMARK · fiscal years 2014 to 2026Named on NCT01609790
- Radiation Therapy Oncology GroupU10CA021661 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI Walter J. Curran · fiscal years 1985 to 2013Named on NCT01609790
Most cited trial papers
Clinical-trial papers with this author name in glioblastoma, ranked by citations from NIH iCite, fetched 2026-11-12 12:40 UTC. The ranking covers the 200 most relevant of 22 PubMed records, and a shared surname and initials can bring in a namesake. All 22 on PubMed
- 1,171 citationsRCR 43.0
- 256 citationsRCR 20.9
- Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial.J Clin Oncol · 2019146 citationsRCR 5.1
- Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02.Neuro Oncol · 2018116 citationsRCR 4.0
- Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma.Neuro Oncol · 2015109 citationsRCR 3.3
- A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients.Clin Cancer Res · 201593 citationsRCR 3.0
- Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02.Neuro Oncol · 201291 citationsRCR 2.4
- Phase 2 study of dose-intense temozolomide in recurrent glioblastoma.Neuro Oncol · 201375 citationsRCR 2.2
- A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy.Neuro Oncol · 201655 citationsRCR 2.1
- Phase I study of vorinostat in combination with temozolomide in patients with high-grade gliomas: North American Brain Tumor Consortium Study 04-03.Clin Cancer Res · 201254 citationsRCR 1.4